News

2013.10.30 Press Release

Discovery of new biomarker for Dengue virus infection -Proposal of Galectin-9 as a danger signaling molecule -

A research group led by Professor Toshio Hattori of Tohoku University Graduate School of Medicine and the International Research Institute of Disaster Science at Tohoku University has discovered a new biomarker for Dengue virus infections which infects 100 million people every year. The study determined for first time that galectin-9 levels are elevated in Dengue virus infected patients in correlation with the progressive severity of their infections. The research was conducted in collaboration with the San Lazaro Hospital, Kagawa University, University of Hawaii, and Nagasaki University. The research results were published in the online edition of the Journal of Clinical Virology on October 27, 2013. The paper's title is "Galectin-9 Plasma Levels Reflect Adverse Hamatological and Immunological Features in Acute Dengue Virus Infection."

More information (Japanese)

[Contact]
Professor Toshio Hattori
Department of Emerging Infectious Diseases
Tohoku University Graduate School of Medicine
Department of Disaster-related Infectious Disease
International Research Institute of Disaster Science, Tohoku University
TEL: +81-22-717-8220
E-mail: toshatto*med.tohoku.ac.jp (Replace * with @)

(Public Relations)
Lecturer Hitoshi Inada
Public Relations Office of Tohoku University Graduate School of Medicine
TEL: +81-22-717-7891
FAX: +81-22-717-8187
E-mail: hinada*med.tohoku.ac.jp (Replace * with @)